Llanos, Anastacio C.
HRN: 22-55-99 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/02/2023
02/09/2023
IV
500mg
Every 6H
Tetanus Infection
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes